We hypothesize that stroke-induced dysbiosis leads to a loss of essential microbiota-derived AHR ligands and that restoring the balance between host-derived (Kyn-based) and microbiota-derived (indole-based) ligands of AHR can have therapeutic benefits after stroke. This evidence concerns the gene AHR and Stroke.